Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INSMED Inc Director's Dealing 2021

Jan 6, 2021

30150_dirs_2021-01-06_0a893079-977a-445a-9863-b907bd2c49d1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2020-12-30

Reporting Person: Lewis William (Director, Chair & CEO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-12-30 Stock Option (right to buy) $3.40 G 30630 Disposed 2022-09-10 Common Stock (30360) Direct
2020-12-30 Stock Option (right to buy) $3.40 G 30630 Acquired 2022-09-10 Common Stock (30630) Indirect
2020-12-30 Stock Option (right to buy) $4.55 G 186170 Disposed 2022-09-28 Common Stock (186170) Direct
2020-12-30 Stock Option (right to buy) $4.55 G 186170 Acquired 2022-09-28 Common Stock (186170) Indirect
2020-12-30 Stock Option (right to buy) $14.24 G 55500 Disposed 2023-10-31 Common Stock (55500) Direct
2020-12-30 Stock Option (right to buy) $14.24 G 55500 Acquired 2023-10-31 Common Stock (55500) Indirect
2020-12-30 Stock Option (right to buy) $12.58 G 50000 Disposed 2024-06-02 Common Stock (50000) Direct
2020-12-30 Stock Option (right to buy) $12.58 G 50000 Acquired 2024-06-02 Common Stock (50000) Indirect
2020-12-30 Stock Option (right to buy) $13.67 G 175530 Disposed 2027-01-05 Common Stock (175530) Direct
2020-12-30 Stock Option (right to buy) $13.67 G 175530 Acquired 2027-01-05 Common Stock (175530) Indirect
2020-12-30 Stock Option (right to buy) $12.44 G 83334 Disposed 2023-05-23 Common Stock (83334) Direct
2020-12-30 Stock Option (right to buy) $12.44 G 83334 Acquired 2023-05-23 Common Stock (83334) Indirect
2021-01-04 Stock Option (right to buy) $12.44 J 83334 Disposed 2023-05-23 Common Stock (83334) Indirect
2020-12-30 Stock Option (right to buy) $12.44 G 83333 Disposed 2023-05-23 Common Stock (83333) Direct
2020-12-30 Stock Option (right to buy) $12.44 G 83333 Acquired 2023-05-23 Common Stock (83333) Indirect
2021-01-04 Stock Option (right to buy) $12.44 J 83333 Disposed 2023-05-23 Common Stock (83333) Indirect
2020-12-30 Stock Option (right to buy) $12.44 G 67257 Disposed 2023-05-23 Common Stock (67257) Direct
2020-12-30 Stock Option (right to buy) $12.44 G 67257 Acquired 2023-05-23 Common Stock (67257) Indirect
2021-01-04 Stock Option (right to buy) $12.44 J 67257 Disposed 2023-05-23 Common Stock (67257) Indirect
2020-12-30 Stock Option (right to buy) $14.24 G 57000 Disposed 2023-10-31 Common Stock (57000) Direct
2020-12-30 Stock Option (right to buy) $14.24 G 57000 Acquired 2023-10-31 Common Stock (57000) Indirect
2021-01-04 Stock Option (right to buy) $14.24 J 57000 Disposed 2023-10-31 Common Stock (57000) Indirect
2020-12-30 Stock Option (right to buy) $10.85 G 245950 Disposed 2026-05-19 Common Stock (245950) Direct
2020-12-30 Stock Option (right to buy) $10.85 G 245950 Acquired 2026-05-19 Common Stock (245950) Indirect
2021-01-04 Stock Option (right to buy) $10.85 J 245950 Disposed 2026-05-19 Common Stock (245950) Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (right to buy) $12.44 2023-05-23 Common Stock (83334) 83334 Indirect
Stock Option (right to buy) $12.44 2023-05-23 Common Stock (83333) 83333 Indirect
Stock Option (right to buy) $12.44 2023-05-23 Common Stock (67257) 67257 Indirect
Stock Option (right to buy) $14.24 2023-10-31 Common Stock (57000) 57000 Indirect
Stock Option (right to buy) $10.85 2026-05-19 Common Stock (245950) 245950 Indirect

Footnotes

F1: The reported transactions involve the reporting person's transfer of options to a family trust, ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A 11/1/2020. Members of the reporting person's immediate family are the sole beneficiaries of the trust.

F2: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

F3: The options were granted on January 9, 2017 and become exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

F4: The reported transactions involve a gift of securities by the reporting person to his spouse.

F5: These options became exercisable upon the achievement of certain performance criteria.

F6: The reported transactions involve transfers of options from the reporting person's spouse to a family trust, ARTICLE 4 TRUST UNDER KATIE PROCTER DYNASTY TRUST, of which the reporting person is a trustee. The reporting person and members of the reporting person's immediate family are the sole beneficiaries of the trust.